Journal article
Research Priorities for Endometriosis: Recommendations from a Global Consortium of Investigators in Endometriosis
PAW Rogers, GD Adamson, M Al-Jefout, CM Becker, TM D'Hooghe, GAJ Dunselman, A Fazleabas, LC Giudice, AW Horne, ML Hull, L Hummelshoj, SA Missmer, GW Montgomery, P Stratton, RN Taylor, L Rombauts, PT Saunders, K Vincent, KT Zondervan
Reproductive Sciences | SPRINGER HEIDELBERG | Published : 2017
Abstract
The 3rd International Consensus Workshop on Research Priorities in Endometriosis was held in São Paulo on May 4, 2014, following the 12th World Congress on Endometriosis. The workshop was attended by 60 participants from 19 countries and was divided into 5 main sessions covering pathogenesis/pathophysiology, symptoms, diagnosis/classification/prognosis, disease/symptom management, and research policy. This research priorities consensus statement builds on earlier efforts to develop research directions for endometriosis. Of the 56 research recommendations from the 2011 meeting in Montpellier, a total of 41 remained unchanged, 13 were updated, and 2 were deemed to be completed. Fifty-three new..
View full abstractGrants
Awarded by Medical Research Council
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The workshop was funded by the World Endometriosis Society (WES) and the World Endometriosis Research Foundation (WERF). CMB holds a research grant from Bayer Health Care. HC has received travel support from AbbVie, Bayer Pharma, Gedeon Richter, Preglem, and Vifor Pharma, and holds research grants from Bayer Pharma, Preglem, the MRC (UK), and EME Program (MRC/NIHR-UK). TMD has received grants from Ferring, Merck Serono, MSD, Besins, Pharmaplex, and has received travel support from Ferring, Merck Serono and MSD. AF has grants from the NIH. IF holds a research grant from the Puerto Rico Science Technology and Research Trust. JG holds a research grant from Bayer Health Care. LCG holds a research grant from the NIH and is a shareholder in Merck and Pfizer. LGG has received research funding from Amgen and Boehringer Ingelheim. AWH holds research grants from NIHR/EME, HTA, and Chief Scientist Office. MLH holds research grants from AbbVie and Origio, has received travel expenses from Merck-Serono and Ferring, and is on the Medical Advisory board of Vifor Pharma Pty. NPJ has received travel expenses from Bayer Pharma, Merck-Serono, and MSD, and holds a research grant from AbbVie. GWM holds research grants from the Australian National Health and Medical Research Council. LR is a shareholder in Monash IVF. PTS holds a program grant from the UK Medical Research Council and a grant for Target from Bayer Pharma. PS has received research support by Allergan for the use of botulinum toxin a in studies of endometriosis-associated CPP. KV holds a research grant from Bayer Health Care. CCW holds research grants from the RGC General Research Fund (475012) and the ITC Innovation and Technology Fund (ITS/209/12). KTZ holds a research grant from Bayer Health Care Ltd.